Phibro Animal Health develops and sells animal health and mineral nutrition products for livestock, poultry, and aquaculture. Its portfolio includes medicated feed additives, vaccines, and nutritional specialties used to support animal performance and disease management. Primary customers are producers, feed mills, and distributors in commercial animal agriculture worldwide.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 347.8 | — | 20.9 | 63.9% |
| Q2 2025 | 378.7 | — | 17.2 | 3.7% |
| Q3 2025 | 363.9 | — | 26.5 | 87.1% |
| Q4 2025 | 373.9 | — | 27.5 | 25.5% |
| Q1 2026 | 383.5 | 10.3% | 24 | 15.1% |
| Q2 2026 | 396.8 | 4.8% | 21.7 | 26.1% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Allient Inc. (ALNT), Liberty Latin America Ltd. (LILAK), Stoke Therapeutics, Inc. (STOK), Generate Biomedicines, Inc. (GENB), Cracker Barrel Old Country Store, Inc. (CBRL), ConnectOne Bancorp, Inc. (CNOB)